TITRE | (EN) A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center, International Study of Durvalumab or Durvalumab and Tremelimumab as Consolidation Treatment for Patients With Limited Stage Small Cell Lung Cancer Who Have Not Progressed Following Concurrent Chemoradiation Therapy |
PROTOCOLE ID | ADRIATIC |
CLINICAL TRIAL.gov ID | NCT03703297 |
TYPE(S) DE CANCER | Poumon à petites cellules |
PHASE | Phase III |
TYPE D'ÉTUDE | Traitement |
INSTITUTION |
CENTRE UNIVERSITAIRE DE SANTE MCGILL
1001 boul. Décarie |
VILLE | Montréal |
INVESTIGATEUR(RICE) PRINCIPAL(E) | Scott Owen |
COORDONATEUR(RICE) |
Corneille Bashagaluke corneille.bashagaluke@muhc.mcgill.ca 514-934-1934 poste 34907 |
STATUT | Fermé |
CRITÈRES D'ÉLIGIBILITÉ | (EN)
|
CRITÈRES D'EXCLUSION | (EN)
|